E-LIB Suche - Ergebnisse für: Teppei Yamaguchi

1

Unrealistic expectations and disclosure of incurability in ..:

Hasegawa, Takaaki ; Okuyama, Toru ; Uemura, Takehiro...
Supportive Care in Cancer. 32 (2024) 7 - p. , 2024

Link: https://doi.org/10.1007/..

2

Candidate tumor-specific CD8+T cell subsets identified in t..:

Sugita, Yusuke ; Muraoka, Daisuke ; Demachi-Okamura, Ayako...
OncoImmunology. 13 (2024) 1 - p. , 2024

Link: https://doi.org/10.1080/..

3

EML4-ALK Variant 3a/b as a mechanism of osimertinib resista..:

Yamaguchi, Teppei ; Masago, Katsuhiro ; Sasaki, Eiichi...
Cancer Genetics. 280-281 (2024) - p. 13-16 , 2024

Link: https://doi.org/10.1016/..

4

Prediction of prognosis in lung cancer using machine learni..:

Fujimoto, Daichi ; Hayashi, Hidetoshi ; Murotani, Kenta...
Lung Cancer. 194 (2024) - p. 107896 , 2024

Link: https://doi.org/10.1016/..

5

The incidence of drug-induced interstitial lung disease cau..:

Fujiwara, Yutaka ; Shimomura, Kazuhiro ; Yamaguchi, Teppei...
Frontiers in Oncology. 14 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

6

Efficacy of chemotherapy plus immune checkpoint inhibitors ..:

Yamaguchi, Teppei ; Shimizu, Junichi ; Matsuzawa, Reiko...
BMC Cancer. 24 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

7

First-line nivolumab plus ipilimumab with or without chemot..:

Imai, Hisao ; Kijima, Takashi ; Azuma, Koichi...
Japanese Journal of Clinical Oncology. 54 (2024) 4 - p. 452-462 , 2024

Link: https://doi.org/10.1093/..

8

Multicenter, Retrospective Study to Evaluate Necitumumab Pl..:

Murata, Yasunori ; Tanzawa, Shigeru ; Misumi, Toshihiro...
JTO Clinical and Research Reports. 4 (2023) 12 - p. 100593 , 2023

Link: https://doi.org/10.1016/..

9

Liquid biopsy detects genomic drivers in NSCLC without EGFR..:

Uemura, Takehiro ; Kenmotsu, Hirotsugu ; Hazama, Daisuke...
Cancer Medicine. 12 (2023) 23 - p. 21097-21110 , 2023

Link: https://doi.org/10.1002/..

10

Elements of End-of-Life Discussions Associated With Patient..:

Hasegawa, Takaaki ; Okuyama, Toru ; Uemura, Takehiro...
The Oncologist. 29 (2023) 2 - p. e282-e289 , 2023

Link: https://doi.org/10.1093/..

11

Efficacy and safety of second-line therapy of docetaxel plu..:

Matsuzawa, Reiko ; Morise, Masahiro ; Ito, Kentaro...
eClinicalMedicine. 66 (2023) - p. 102303 , 2023

Link: https://doi.org/10.1016/..

12

Risk factors for pneumonitis in patients with non‐small cel..:

Yamaguchi, Teppei ; Shimizu, Junichi ; Oya, Yuko...
Thoracic Cancer. 13 (2022) 5 - p. 724-731 , 2022

Link: https://doi.org/10.1111/..

13

Improvement of sep-CMA-ES for Optimization of High-Dimensio..:

, In: 2022 IEEE Symposium Series on Computational Intelligence (SSCI),

Yamaguchi, Teppei ; Uchida, Kento ; Shirakawa, Shinichi - p. 1659-1668 , 2022

Link: https://doi.org/10.1109/..

14

Prognostic Awareness and Discussions of Incurability in Pat..:

Hasegawa, Takaaki ; Okuyama, Toru ; Uemura, Takehiro...
The Oncologist. 27 (2022) 11 - p. 982-990 , 2022

Link: https://doi.org/10.1093/..

15

Predictive risk factors for pneumothorax after transbronchi..:

Gotoh, Yusuke ; Yamaguchi, Teppei ; Yatsuya, Hiroshi...
BMC Pulmonary Medicine. 21 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..